# Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

> **NCT05164731** · PHASE3 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 880 (estimated)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Vaccine, Inactivated (Vero Cell)

## Key facts

- **NCT ID:** NCT05164731
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-16
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164731, "Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT05164731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*